Clinical Trial Update: iTear Single-center, Open-label, Single-arm Study [Phase 4]

View source ↗

Summary

Phase 4, single-center, open-label, single-arm trial sponsored by The University of Hong Kong evaluating dry eye conditions. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome
• Meibomian Gland Dysfunction

Snippet

Sponsor: The University of Hong Kong | Conditions: Dry Eye Disease, Dry Eye Syndromes | Phase 4 | Status: NOT_YET_RECRUITING